| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Corporate Merger Acquisitions |
|
Main Subject - Corporate Merger Acquisitions
Corporate mergers and acquisitions are quite common these days. In 2004 deals worth over $800 bil According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product lion were concluded, up 50% from the previous year. This trend is expected to sustain during the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rest of the decade. Basically, mergers and acquisitions are meant for consolidation and growth o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. f a corporation. For instance, a retail chain, which has a strong presence in the East Coast, wan here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ts to expand its business to the West. It could either put up its own facilities, which is a time d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro -consuming process, or acquire a large chain or several local chains. There could be other reaso ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ns as well for mergers and acquisitions. A profit-making company could benefit from tax write-off easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi by acquiring one that is running at a loss. Certain mergers and acquisitions complement each oth nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically er's capabilities and facilities. A small company with a good product but poor sales could gain b and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y merging with or yielding to acquisition bid by an organization that has a strong marketing setu ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi . Different types of mergers and acquisitions are resorted to. Sometimes two solid corporations ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a merge to become a much stronger entity. Another is a fledging company merging with a prosperous dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod corporation. We often see subsidiaries being merged with the parent company. There is also a rath cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin er rare scenario called 'reverse merger' where the parent company merges with a subsidiary. If an tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Indian company merges with its U.S. subsidiary, it becomes an American company with operations i t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel n India. While many mergers and acquisitions are negotiated, hostile acquisitions also take plac ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e. Here the company that is acquiring secretly buys controlling shares of the target company by u y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sing third parties. Several big corporations are constantly in search of potential targets. Fina . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ncial analysts help them in this process. Printed and electronic directories that provide details elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip of companies, and software that helps to analyze company strengths and weaknesses, are available tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Communication for Small Businesses Purchase Order Financing - A Tool To Finance Your Growing Orders
|